HindustanTimes Sun,31 Aug 2014

Strides promoter to make Rs. 1,400 cr from sale of Agila unit to Mylan

Manu P Toms , Hindustan Times  New Delhi, September 24, 2013
First Published: 01:14 IST(24/9/2013) | Last Updated: 01:18 IST(24/9/2013)

Strides Arcolab, which recently sold its Agila unit to the US-based Mylan Inc for $1.6 billion (about Rs. 10,000 crore) may return half that amount (or about Rs. 5,000 crore) to shareholders as a special dividend, sources said.


The implication: shareholders will get Rs. 750-800 per share, which closed at Rs. 901.70 on Monday. Chairman and managing director Arun Kumar, a first generation entrepreneur who owns a 28% stake in Strides, is expected to receive about Rs. 1,400 crore as dividend.

The company did not respond to phone calls and emails from HT on the issue.

In February this year, Mylan and Strides Arcolab signed the agreement under which the US drug major acquired Agila Specialties, the Australian injectible medicine business of Strides.

Foreign institutional investors hold 51.74%  domestic institutional investors 8.07% and retail investors 12.8% in Strides Arcolab.

“It isn’t common for companies to return money from the sale of assets to shareholders,” said an analyst at a leading investment bank on condition of anonymity.

The Prime Minister’s office had cleared Strides Arcolab-Mylan deal in mid August overruling the concerns raised by Department of Industrial Policy and Promotion and Ministry of Health.

more from Business

Airlines claim some airports charging for landing small planes

Some Indian airlines have claimed that they had to pay landing charges for small aircraft at several airports where rules do not permit such payments and urged the government to look into the matter and help them improve connectivity to non-metro cities.
Most Popular
Copyright © 2014 HT Media Limited. All Rights Reserved